Estrogen/Progesterone Receptor Status

Estrogen/Progesterone receptor status, short for ER and PR status, is a test to determine if a breast cancer tumor is positive for estrogen and progesterone receptors.

What does the test result mean?

ER and PR testing of breast tumor tissue determines if one or both types of receptors are present. The results include:

  • ER-positive and PR-positive: a better than average prognosis and a more intense response to endocrine therapy.
  • ER-negative but PR-positive, or ER-positive but PR-negative: still benefiting from endocrine therapy but may having a decreased response.
  • ER-negative and PR-negative: not likely to benefit from endocrine therapy.

An individual’s response to endocrine therapy will depend on a variety of factors, but typical response rates include:

  • ER-positive, PR-positive: 75-80%
  • ER-positive, PR-negative: 40-50%
  • ER-negative, PR-positive: 25-30%
  • ER-negative, PR-negative: 10% or less

 

Keywords: estrogen/progesterone receptor status; ER and PR status

* The contents of this HTQ Site are for informational and communicational purposes only. The information provided by HTQ, HTQ employees, others appearing on the Site at the invitation of HTQ, or other visitors to the Site is NOT a medical advice.The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the HTQ Site!